ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 109 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,755,000 | +12.5% | 93,781 | +28.1% | 0.01% | +25.0% |
| Q4 2015 | $2,449,000 | -12.8% | 73,229 | -5.7% | 0.00% | -20.0% |
| Q3 2015 | $2,807,000 | -10.3% | 77,653 | +11.6% | 0.01% | 0.0% |
| Q2 2015 | $3,130,000 | +781.7% | 69,565 | +500.4% | 0.01% | +400.0% |
| Q1 2015 | $355,000 | -86.4% | 11,586 | -77.3% | 0.00% | -80.0% |
| Q4 2014 | $2,612,000 | +45.3% | 51,099 | +12.5% | 0.01% | +66.7% |
| Q3 2014 | $1,798,000 | +1.6% | 45,437 | -3.4% | 0.00% | 0.0% |
| Q2 2014 | $1,770,000 | +11.0% | 47,033 | +10.4% | 0.00% | 0.0% |
| Q1 2014 | $1,594,000 | +8.4% | 42,606 | +6.1% | 0.00% | 0.0% |
| Q4 2013 | $1,471,000 | – | 40,146 | +200630.0% | 0.00% | – |
| Q3 2013 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
| Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
| ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
| Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
| Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
| Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
| AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
| Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |